ARKG

Fund Description
The Fund is concentrated in any industry or group of industries in the health care sector, including, in particular, issuers having their principal business activities in the biotechnology industry. Other industries in the health care sector include medical laboratories and research, drug manufacturers and agricultural chemicals.
Fund Profile
Fund Name ARK Genomic Revolution Multi-Sector ETF
Fund Exchange Ticker ARKG
Fund Sponsor ARK Funds
Fund ISIN US00214Q3020
Net Expense Ratio 0.75 %
Fund Inception Date 31 October 2014
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific Global or ExUS Equities - Factor & Thematic
Asset Class Equities (Stocks)
Index Linked Active
Index Name Not Applicable
Index Provider Not Applicable
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Funds Combining Developed & Emerging Exposure
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 18 January 2019
Asset Under Management 314.97 Million (USD)
1 Month Total Return 13.79 %
Year To Date Return 20.23 %
1 Year Total Return 13.03 %
3 Year Annualized Total Return 19.18 %
NAV 28.7514
Share Outstanding 10,955,000
Top 10 Holdings (18 January 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
ILLUMINA INC ILMN EQUI 0.0895
INVITAE CORP NVTA EQUI 0.0874
INTELLIA THERAPEUTICS INC NTLA EQUI 0.0716
EDITAS MEDICINE INC EDIT EQUI 0.0624
NANOSTRING TECHNOLOGIES INC NSTG EQUI 0.0508
VERACYTE INC VCYT EQUI 0.0506
BLUEBIRD BIO INC BLUE EQUI 0.0471
MEDIDATA SOLUTIONS INC MDSO EQUI 0.0464
CRISPR THERAPEUTICS AG CRSP EQUI 0.0402
IONIS PHARMACEUTICALS INC IONS EQUI 0.0346